Mescher Lab Post Doctoral Fellow Alumni
Post Doctoral Fellows
Pujya Agarwal, Ph.D
Fellowship dates: 2007-2009
Research Emphasis: Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory., Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation.
Current Position: Data Analyst/SAS Programmer, Minneapolis, MN
Contact Info: agar0050@umn.edu 
Jodi Goldberg, Ph.D.
Fellowship dates: 1998-2002
Research Emphasis: In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
Current Position: Professor of Biology, Hamline University, St. Paul, MN
Contact Info: jgoldberg01@hamline.edu
Lynn Heltemes-Harris, Ph.D.
Fellowship dates: 2009-2015
Research Emphasis: Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control.
Current Position: Senior Research Associate, Center for Immunology, Farrar Lab, University of Minnesota, Minneapolis, MN
Contact Info: harr0905@umn.edu 
Royce Robinson-Lawler, Ph.D.
Fellowship dates: 1993-1995
Research Emphasis:
Current Position: Homemaker, Minneapolis, MN
Contact Info: roycelawler@comcast.net
Hsiao-Tzu (Jessie) Ni, M.S., Ph.D.
Fellowship dates: 1995-1997
Research Emphasis: LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity, Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. and Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells.
Current Position: Chief Scientific Officer at Irvine Scientific, Irvine, CA
Contact Info: jessieni@yahoo.com
Elena Savelieva, Ph.D.
Fellowship dates: 1993-1996
Research Emphasis: Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen.
Current Position:
Contact Info:
Protul Shrikant, Ph.D.
Fellowship dates: 1996-2000
Research Emphasis: Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis.,CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. and Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness.
Current Position: Professor of Immunologyand Professor of Pharmacology, Mayo Clinic, Scottsdale, AZ
Contact Info: Shrikant.Protul@mayo.edu
Xiaodan Wang, M.D., Ph.D.
Fellowship dates: 2012-2016
Research Emphasis: Microarray gene expression analysis, Cellular Immunology (including bone marrow chimeras, organ culture, intra-thymic injection, adoptive transfer, rare cell enrichment.
Current Position: Flow Cytometry Core Manager, University of Minnesota
Contact Info: shiartan@hotmail.com
Paul Weaver, Ph.D.
Fellowship dates: 1997-2001
Research Emphasis:
Current Position: Patent Agent, Kagan Binder Intellectual Property Attorneys, Stillwater, MN
Contact Info: paulweaver@kaganbinder.com
Zhengguo Xiao, DVM, M.S., Ph.D
Fellowship dates: 2004-2008
Research Emphasis: Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation., The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses., Programming for CD8 T cell memory development requires IL-12 or type I IFN.
Current Position: Associate Professor, University of Maryland, College Park, MD
Contact Info: xiao0028@umd.edu